Industry, Latvia, Markets and Companies, Medicine
International Internet Magazine. Baltic States news & analytics
Friday, 26.04.2024, 01:26
Latvia: Grindex board chairman Juris Bundulis steps dow
BC, Riga, 22.01.2020.
Print version
Print versionJuris Bundulis, the board chairman of Grindex pharmaceutical company, has stepped down from his position, the company said in a statement to the Nasadaq Riga stock exchange.
 |
|---|
The company's representatives informed that the company received a resignation tender from Bundulis on January 21.
Until further decisions the board of Grindex continues to work in composition of two board members – Juris Hmelnickis and Janis Romanovskis.
Bundulis has been in the position since 2012.
As reported, Grindex Group posted EUR 106.564 mln in turnover for the first nine months of 2019, up 4% from the respective period in 2018, while the group’s profit rose 17.6% to EUR 8.906 mln.
Grindex is quoted on the Main List of Nasdaq Riga stock exchange.
Other articles:
- 28.01.2022 BONO aims at a billion!
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer
- 29.12.2020 В Rietumu и в этот раз создали особые праздничные открытки и календари 2021
- 29.12.2020 Latvia to impose curfew, state of emergency to be extended until February 7
«The Baltic Course» Is Sold and Stays in Business!
